Education
About Us
Working with TipRanks
Follow Us
Protalix Biotherapeutics (PLX)
:PLX
Total Valuation
Protalix has a market cap or net worth of $164.25M. The enterprise value is $92.23M.
Market Cap$164.25M
Enterprise Value$92.23M
Share Statistics
Protalix has 79,732,120 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding79,732,120
Owned by Insiders4.68%
Owned by Institutions1.89%
Financial Efficiency
Protalix’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 5.44%.
Return on Equity (ROE)0.07
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)5.44%
Return on Capital Employed (ROCE)0.08
Revenue Per Employee250.70K
Profits Per Employee13.77K
Employee Count213
Asset Turnover0.73
Inventory Turnover1.14
Valuation Ratios
The current PE Ratio of Protalix is 27.8. Protalix’s PEG ratio is ―.
PE Ratio27.8
PS Ratio―
PB Ratio―
Price to Fair Value3.16
Price to FCF―
Price to Operating Cash Flow-54.83
PEG Ratio―
Income Statement
In the last 12 months, Protalix had revenue of 53.40M and earned 2.93M in profits. Earnings per share was 0.04.
Revenue53.40M
Gross Profit29.08M
Operating Income3.92M
Pretax Income4.15M
Net Income2.93M
EBITDA6.52M
Earnings Per Share (EPS)0.04
Cash Flow
In the last 12 months, operating cash flow was -2.19M and capital expenditures -1.25M, giving a free cash flow of -3.44M billion.
Operating Cash Flow-2.19M
Free Cash Flow-3.44M
Free Cash Flow per Share-0.04
Dividends & Yields
Protalix pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.68
52-Week Price Change101.96%
50-Day Moving Average1.64
200-Day Moving Average1.99
Relative Strength Index (RSI)67.94
Average Volume (3m)700.91K
Important Dates
Protalix upcoming earnings date is Nov 17, 2025, TBA (Confirmed).
Last Earnings DateAug 14, 2025
Next Earnings DateNov 17, 2025
Ex-Dividend Date―
Financial Position
Protalix as a current ratio of 2.34, with Debt / Equity ratio of 10.72%
Current Ratio2.34
Quick Ratio1.52
Debt to Market Cap0.01
Net Debt to EBITDA-2.18
Interest Coverage Ratio3.69
Taxes
In the past 12 months, Protalix has paid 1.22M in taxes.
Income Tax1.22M
Effective Tax Rate0.29
Enterprise Valuation
Protalix EV to EBITDA ratio is 18.73, with an EV/FCF ratio of 16.52.
EV to Sales2.29
EV to EBITDA18.73
EV to Free Cash Flow16.52
EV to Operating Cash Flow14.08
Balance Sheet
Protalix has $33.40M in cash and marketable securities with $5.35M in debt, giving a net cash position of $28.05M billion.
Cash & Marketable Securities$33.40M
Total Debt$5.35M
Net Cash$28.05M
Net Cash Per Share$0.35
Tangible Book Value Per Share$0.60
Margins
Gross margin is 57.53%, with operating margin of 7.34%, and net profit margin of 5.49%.
Gross Margin57.53%
Operating Margin7.34%
Pretax Margin7.78%
Net Profit Margin5.49%
EBITDA Margin12.21%
EBIT Margin9.77%
Analyst Forecast
The average price target for Protalix is $15.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$15.00
Price Target Upside628.16% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast62.79%
EPS Growth Forecast―